References
- Bøjholm S, Børup C, Kvist J, Petersen I-M, Honoré P. A double-blind study of femoxetine and amidtriptyline in patients with endogenous depression. Nord. Psykiat. Tidskr. 1979; 33: 455–460
- Børup C, Petersen I-M, Honoré P, Wetterberg L. Reduction of whole blood serotonin in depressed patients treated with a new, selective serotonin-uptake inhibitor, femoxetine. Psycho-pharmacology 1979; 63: 241–243
- Coppen A, Montgomery S A, Gupta R K, Bailey J E. A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Brit. J. Psychiat. 1976; 128: 479–485
- Coppen A, Ghose K, Montgomery S, Rama Rao V A, Bailey J, Jorgensen A. Continuation therapy with amitriptyline in depression. Brit. J. Psychiat. 1978a; 133: 28–33
- Coppen A, Chose K, Rama R, Bailey J, Peet M. Mianserin and lithium in the prophylaxis of depression. Brit. J. Psychiat. 1978b; 133: 206–210
- Heltberg J, Larsen J K, Kirk L, Bjørum N. Resultater af behandling af depressive tilstand med FG 4963 — erfaringer fra hidtidige pilotforsøg. Nord. Psykiat. Tidskr. 1975; 29: 485–486
- Hestbech J, Hansen H E, Amdisen A, Olsen S. Chronic renal lesions following long-term treatment with lithium. Kidney Int. 1977; 12: 205–13
- Lundin L, Dencker S J, Dahl L E, Honoré P (1980) A double blind controlled study of the effect of femoxetine and desipramine in the treatment of depressive illness. Paper presented at the annual meeting in the Scandinavian Society for Psycho-pharmacology, Copenhagen, March, 211980
- Mindham R HS, Howland C, Shepherd M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol. Med. 1973; 3: 5–17
- Prien R F, Nett C J, Caffey E M. Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen Psychiatry 1973; 29: 420–425